Tesetaxel: Phase IIb started

Genta began an open-label, international Phase IIb trial to compare 27 mg/m 2 oral tesetaxel on day 1 of a 21-day cycle or 15 mg/m 2 oral tesetaxel on days 1, 8 and 15 of a 28-day cycle vs. Xeloda ca...